0001144204-12-012323.txt : 20120301 0001144204-12-012323.hdr.sgml : 20120301 20120301161007 ACCESSION NUMBER: 0001144204-12-012323 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120228 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120301 DATE AS OF CHANGE: 20120301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KEWAUNEE SCIENTIFIC CORP /DE/ CENTRAL INDEX KEY: 0000055529 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 380715562 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-05286 FILM NUMBER: 12657815 BUSINESS ADDRESS: STREET 1: 2700 W FRONT ST CITY: STATESVILLE STATE: NC ZIP: 28677 BUSINESS PHONE: 7048737202 MAIL ADDRESS: STREET 1: P O BOX 1842 CITY: STATESVILLE STATE: NC ZIP: 28687-1842 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/ DATE OF NAME CHANGE: 19861216 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE MANUFACTURING CO DATE OF NAME CHANGE: 19680108 8-K 1 v304075_8k.htm FORM 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) February 28, 2012

 

 

Kewaunee Scientific Corporation

 

(Exact name of registrant as specified in its charter)

Delaware 0-5286 38-0715562
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)

 

2700 West Front Street

Statesville, North Carolina

(Address of principal executive offices)

 

 

28677

(Zip Code)

 

  

Registrant’s telephone number, including area code 704-873-7202

 

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 2.02 Results of Operations and Financial Condition

 

On February 28, 2012, Kewaunee Scientific Corporation issued a press release announcing its financial results for the third quarter ended January 31, 2012. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits:

 

Exhibit No.

99.1Press Release of Kewaunee Scientific Corporation dated February 28, 2012

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    (Registrant)
       Kewaunee Scientific Corporation
       
Date:  February 28, 2012      /s/ D. Michael Parker
     

D. Michael Parker

Senior Vice President, Finance

      Chief Financial Officer

 

 

2

 

EX-99.1 2 v304075_ex99-1.htm

Kewaunee Scientific Announces Results for Third Quarter

STATESVILLE, N.C., Feb. 28, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced the financial results for its third quarter ended January 31, 2012.

Sales for the quarter were $21,574,000, down 4% from sales of $22,568,000 in the third quarter last year. Additional sales of $720,000 for products manufactured late in the quarter were not recorded as a sale because the customer failed to secure international shipping containers and take delivery of the products. In addition, a continuing decline in orders for publicly-funded K-12 educational projects, and lower sales of technical furniture products adversely affected sales results. Partially offsetting the impact of these factors was a 28% increase in international sales during the quarter. The order backlog was $77.1 million at January 31, 2012, as compared to $68.2 million at January 31, 2011.

A net loss of $122,000, or $0.05 per diluted share, was reported for the quarter, as compared to net earnings of $86,000, or $0.03 per diluted share, in the third quarter last year. Earnings for the quarter were unfavorably affected by the lower sales volume, aggressive pricing in the marketplace, particularly for wood furniture, and continuing higher costs paid for steel and epoxy resin raw materials. Earnings were also unfavorably impacted by a significant under-absorption of factory overhead costs resulting from the decline in wood furniture orders and after-tax employee severance costs of $78,000 related to headcount reductions in Statesville. Earnings were favorably impacted by significantly improved profits from international operations, lower costs from savings initiatives, and after-tax income of $95,000 related to a property insurance settlement.

During the quarter, the Company implemented additional actions to reduce factory labor and overhead costs, as well as a 13% reduction in the number of administrative and support staff at Statesville. The administrative and support staff reductions are projected to reduce costs by $350,000 each quarter, starting in the fourth quarter. These cost reduction activities follow initiatives previously announced by the Company in the second quarter, that when fully implemented, are projected to reduce annual costs by over $3 million.

Domestic operations sales for the quarter were $17,142,000, down 10% from sales of $19,108,000 in the third quarter last year. Sales were unfavorably impacted by the continuing decline in incoming orders for publicly-funded K-12 educational projects, primarily wood furniture, lower sales of technical furniture products, and the timing of scheduled ship dates for orders in the backlog. Although not reflected in the financial results, bidding activity for larger laboratory projects and small and mid-sized privately-funded projects continued to hold up relatively well, though pricing remains extremely competitive.

International operations sales for the quarter were $4,432,000, up 28% from sales of $3,460,000 in the third quarter last year. Sales benefited from the beginning of shipments for a large project in the order backlog. The Company continues to have a strong backlog of international orders, including a large project that has experienced a lengthy construction delay due to extraordinary building construction complications.

Sales for the nine months ended January 31, 2012 were $73,857,000, up 1% over sales of $73,051,000 in the same period last year. Domestic operations sales were $64,364,000, up 3% over sales of $62,324,000 in the same period last year. International operations sales were $9,493,000, down 12% from sales of $10,727,000 in the same period last year. A net loss of $225,000, or $0.09 per diluted share, was reported for the nine months ended January 31, 2012. This compares to net earnings of $1,598,000, or $0.62 per diluted share, for the same period last year.

The Company continues to have a strong balance sheet. Cash on hand was $4,578,000 at the end of the quarter, as compared to $2,704,000 at the end of the third quarter last year. Working capital was $21,487,000 at January 31, 2012, as compared to $21,341,000 at the end of the third quarter last year. Short-term borrowings under the Company's $15 million bank line of credit were $6,401,000 at the end of the quarter, as compared to $696,000 at the end of the third quarter last year, and total bank borrowings and capital lease obligations were $10,176,000, as compared to $4,752,000 at the end of the third quarter last year. The debt-to-equity ratio was .34-to-1 at the end of the quarter, as compared to .15-to-1 at the end of the third quarter last year.

In January 2012, the Company announced two major changes to its network of domestic dealers that are expected to have significant long-term benefits to the Company. The territories covered by ISEC, Inc., which joined the Company's dealer network in May 2011 responsible for the Rocky Mountain region, were expanded to encompass the entire western United States. Additionally, Nycom, Inc. joined the Kewaunee dealer network responsible for covering 11 states over the Southeastern section of the United States. The expansion with ISEC and addition of Nycom are expected to significantly enhance Kewaunee's presence and competitiveness in their territories.

"An excellent third quarter by our international operations was unfortunately overshadowed by an extremely challenging domestic marketplace," said William A. Shumaker, President and Chief Executive Officer. "Our international operations sales would have shown even better improvement if we had not experienced a shortage of international shipping containers late in the quarter that delayed a number of planned shipments of manufactured products until the next quarter.

"Looking forward over the long-term, I remain optimistic regarding improved earnings. My optimism is based on a number of factors, including the recent strengthening and expansion of our domestic dealer network and our reduced manufacturing and overhead costs. I also think the Company is well established and positioned to take advantage of the growing number of laboratory project opportunities in Asia and the Middle East.

"Regarding the short-term, the international laboratory marketplace remains robust, and we expect this business will continue its improvement. We will also see lower costs as a result of our recent headcount reductions and on-going cost savings initiatives in Statesville. However, I remain concerned about the recession's impact on the domestic demand for our wood products. We are also concerned about the recent significant rise in the price of oil and how it might impact transportation costs and prices paid for epoxy resin raw materials, which are petroleum-based."

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of laboratory, technical and laminate furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets and epoxy resin counters and sinks. Technical furniture products include column systems, slotted-post systems, pedestal systems and stand-alone benches. Laminate furniture includes laminate casework, systems and related products for educational, healthcare and industrial applications.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

Consolidated Statements of Operations

(in thousands, except per share data)

(Unaudited)







Three Months Ended

Nine Months Ended


January 31

January 31


2012

2011

2012

2011






Net sales

$21,574

$22,568

$73,857

$73,051

Cost of products sold

17,803

18,405

62,053

58,472






Gross profit

3,771

4,163

11,804

14,579






Operating expenses

3,990

4,007

11,950

11,953






Operating earnings (loss)

(219)

156

(146)

2,626






Other income

193

1

228

--

Interest expense

(110)

17

(333)

(105)






Earnings (loss) before income taxes

(136)

174

(251)

2,521

Income tax expense (benefit)

(170)

49

(237)

792






Net earnings (loss)

34

125

(14)

1,729






Less: net earnings attributable to





    the noncontrolling interest

156

39

211

131






Net earnings (loss) attributable to





    Kewaunee Scientific Corporation





    Stockholders

$(122)

$86

$(225)

$1,598






Net earnings (loss) per share attributable to





    Kewaunee Scientific Corporation stockholders





          Basic

$(0.05)

$0.03

$(0.09)

$0.62

          Diluted

$(0.05)

$0.03

$(0.09)

$0.62






Weighted average number of common





      shares outstanding (in thousands)





          Basic

2,579

2,576

2,579

2,574

          Diluted

2,579

2,592

2,579

2,583



Condensed Consolidated Balance Sheets

(in thousands)





January 31

April 30


2012

2011


(unaudited)


Assets



Cash and cash equivalents

$3,929

$2,402

Restricted cash

649

553

Receivables, less allowances

20,046

27,346

Inventories

11,762

10,466

Prepaid expenses and other current assets

2,334

1,612

  Total current assets

38,720

42,379

Net property, plant and equipment

15,811

16,575

Other assets

3,890

4,104

Total Assets

$58,421

$63,058




Liabilities and Equity



Short-term borrowings

$6,401

$6,588

Current obligations under capital leases and long-term debt

258

283

Accounts payable

6,608

9,770

Other current liabilities

3,966

3,623

  Total current liabilities

17,233

20,264

Other non-current liabilities

9,316

9,778

  Total liabilities

26,549

30,042

Noncontrolling interest

1,622

1,525

Kewaunee Scientific Corporation stockholders' equity

30,250

31,491

  Total equity

31,872

33,016

Total Liabilities and Equity

$58.421

$63,058



Contact: D. Michael Parker

704/871-3290